Deep Vein Thrombosis (DVT) - Pipeline Review, H2 2016; New Report Launched
Deep Vein Thrombosis (DVT) pipeline therapeutics constitutes close to 10 molecules. Out of which approximately 9 molecules are developed by Companies and remaining by the Universities/Institutes. Global Markets Direct's latest report Deep Vein Thrombosis (DVT) – Pipeline Review, H2 2016, outlays comprehensive information on the therapeutics under development for Deep Vein Thrombosis (DVT), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
View full press release